Dr Reddy's Brings In Kikuchi To Lead North America Generics

Dr Reddy’s has added to its senior leadership team by appointing Marc Kikuchi as CEO of North America Generics. With a record number of US launches in Q3, potentially more in store and now a new leader to steer things through, the firm has improved its outlook for a significant revival in earnings. But risks of delays and competition on certain key anticipated launches in 2019 could dull prospects.

Globe
Reddy's appoints Kikuchi to lead North America Generics • Source: Shutterstock

Dr Reddy’s has appointed Marc Kikuchi as chief executive officer of North America Generics. Noting that Kikuchi has more than two decades of experience in the pharmaceutical industry, the Indian firm said he brings “extensive knowledge and understanding of generics”.

Kikuchi moves to Reddy’s from Zydus Pharmaceuticals where he was CEO for the Americas region since 2016, and prior...

Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Leadership

More from Generics Bulletin